A year-long study found two candidate biomarkers able to predict clinical outcomes in CF, HMGB-1 and free NE activity. Subjects will be enrolled if able to spontaneously produce sputum. The sputum will be collected at baseline, at time of first pulmonary exacerbation, recovery, and 1 year post baseline.
Enrolling by physician discretion only
Investigator Initiated, University of Utah, Cystic Fibrosis Center, Cystic Fibrosis Foundation.
Cori Daines, MD
Osmara Y. Molina de Rodriguez, MS
Cell: (520) 891-6767 or Office: (520) 626-3910